Key Record Dates
ClinicalTrials.gov Identifier: | NCT04324021 |
---|---|
Brief Title: | Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. |
First Submitted : | March 25, 2020 |
First Submitted that Met QC Criteria : | March 25, 2020 |
First Posted : | March 27, 2020 |
Results First Submitted : | November 29, 2021 |
Results First Posted with QC Comments : | December 2, 2021 |
Results First Submitted that Met QC Criteria : | March 3, 2022 |
Results First Posted : | March 10, 2022 |
Last Update Submitted that Met QC Criteria : | March 3, 2022 |
Last Update Posted : | March 10, 2022 |